These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15699365)

  • 1. Blood is thicker than water: the strengths of family-based case-control studies.
    Maraganore DM
    Neurology; 2005 Feb; 64(3):408-9. PubMed ID: 15699365
    [No Abstract]   [Full Text] [Related]  

  • 2. Family-based case-control study of cigarette smoking and Parkinson disease.
    Scott WK; Zhang F; Stajich JM; Scott BL; Stacy MA; Vance JM
    Neurology; 2005 Feb; 64(3):442-7. PubMed ID: 15699372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease and family history.
    Sellbach AN; Boyle RS; Silburn PA; Mellick GD
    Parkinsonism Relat Disord; 2006 Oct; 12(7):399-409. PubMed ID: 16797215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of self-reported ancestry among siblings: implications for genetic association studies.
    Burnett MS; Strain KJ; Lesnick TG; de Andrade M; Rocca WA; Maraganore DM
    Am J Epidemiol; 2006 Mar; 163(5):486-92. PubMed ID: 16421243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation of neurodegenerative disease in ALS kindreds.
    Fallis BA; Hardiman O
    Amyotroph Lateral Scler; 2009 Apr; 10(2):95-8. PubMed ID: 18608094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer risk as modified by family history and smoking.
    Lin J; Spitz MR; Dinney CP; Etzel CJ; Grossman HB; Wu X
    Cancer; 2006 Aug; 107(4):705-11. PubMed ID: 16845665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease.
    Hancock DB; Martin ER; Stajich JM; Jewett R; Stacy MA; Scott BL; Vance JM; Scott WK
    Arch Neurol; 2007 Apr; 64(4):576-80. PubMed ID: 17420321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tests for gene-environment interaction from case-control data: a novel study of type I error, power and designs.
    Mukherjee B; Ahn J; Gruber SB; Rennert G; Moreno V; Chatterjee N
    Genet Epidemiol; 2008 Nov; 32(7):615-26. PubMed ID: 18473390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of the case-control method to the evaluation of screening tests].
    Weiss NS
    Bol Oficina Sanit Panam; 1996 Oct; 121(4):310-7. PubMed ID: 8962667
    [No Abstract]   [Full Text] [Related]  

  • 10. Computing differential sample size for case-control studies of gene-environment interaction.
    Efird JT; Hong MK
    Ethn Dis; 2008; 18(2 Suppl 2):S2-25-9. PubMed ID: 18646316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis use and genetic predisposition for schizophrenia: a case-control study.
    Veling W; Mackenbach JP; van Os J; Hoek HW
    Psychol Med; 2008 Sep; 38(9):1251-6. PubMed ID: 18485264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of invasive meningococcal disease, pregnancy, and confounding.
    Tozzi AE; De Benedetti F; Carsetti R
    Pediatrics; 2005 Sep; 116(3):798-9; author reply 799. PubMed ID: 16140727
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk.
    Powers KM; Smith-Weller T; Franklin GM; Longstreth WT; Swanson PD; Checkoway H
    Parkinsonism Relat Disord; 2006 Apr; 12(3):185-9. PubMed ID: 16364673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: "flexible matching strategies to increase power and efficiency to detect and estimate gene-environment interactions in case-control studies".
    Schill W; Wild P
    Am J Epidemiol; 2004 Jun; 159(11):1107-8; author reply 1108. PubMed ID: 15155296
    [No Abstract]   [Full Text] [Related]  

  • 15. Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease.
    Kang SJ; Scott WK; Li YJ; Hauser MA; van der Walt JM; Fujiwara K; Mayhew GM; West SG; Vance JM; Martin ER
    Mov Disord; 2006 Dec; 21(12):2175-80. PubMed ID: 17044053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.
    Eng PM; Seeger JD; Loughlin J; Clifford CR; Mentor S; Walker AM
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):297-305. PubMed ID: 18215000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional risk factors and acute coronary syndrome during a period of socioeconomic transition: population-based case-control study in Tirana, Albania.
    Burazeri G; Goda A; Sulo G; Stefa J; Roshi E; Kark JD
    Croat Med J; 2007 Apr; 48(2):225-33. PubMed ID: 17436387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of stroke and family history of stroke depends on its subtypes and gender: a family history study in Taiwan.
    Hsu WC; Chen ST; Wu YR; Chang HS; Lyu RK; Lo LS
    Acta Neurol Taiwan; 2009 Sep; 18(3):161-9. PubMed ID: 19960959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between family history of Parkinson's disease and dementia and risk of dementia in Parkinson's disease: A community-based, longitudinal study.
    Kurz MW; Larsen JP; Kvaloy JT; Aarsland D
    Mov Disord; 2006 Dec; 21(12):2170-4. PubMed ID: 17029273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-environment interactions in Parkinson's disease.
    Ross CA; Smith WW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S309-15. PubMed ID: 18267256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.